Form 4: Baxter International Executive Alok Sonig Reports Stock Transaction
SEC Form 4 Filing
Alok Sonig, EVP, Group President, Pharma at Baxter International, reports the forfeiture of 3,054 shares to cover tax withholding related to vested restricted stock units.
Summary
- On September 3, 2024, Alok Sonig, EVP, Group President, Pharma at Baxter International, forfeited 3,054 shares of common stock to cover tax obligations.
- The shares were forfeited at a price of $37.85 per share.
- This transaction resulted from the settlement of vested restricted stock units granted on September 1, 2022.
- Following the transaction, Sonig directly owns 111,603 shares of Baxter International.
- This total includes the automatic reinvestment of dividends.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock. This filing indicates that Alok Sonig, a key executive at Baxter International, has fulfilled tax obligations related to vested stock awards.
Key Dates
| Date | Description |
|---|---|
| 09/01/2022 | Date of grant for the restricted stock units that vested. |
| 09/03/2024 | Date of the transaction (stock forfeiture for tax withholding). |
| 09/05/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.